优质白菜新品种‘暑绿’

 ‘暑绿’系白菜一代杂种，亲本为SW-13和SU-124(矮×苏)。该品种株型直立、束腰，叶片近圆形、翠绿色，叶柄半圆、绿白色。品质佳，株型美观，叶片与叶柄质量比值为0.67，单株质量0.40 kg。高抗炭疽病，抗TuMV、霜霉病和黑斑病。适宜在喜食青梗菜的地区作夏菜、秋菜和秋冬菜栽培。     

显齿蛇葡萄新品种——绿凤

 从中国鄂西地区生长的显齿蛇葡萄植株中选育出优良无性系‘绿凤’, 其叶含总黄酮12.9 % ,总氨基酸16.7 % , 总糖6.92 % , 维生素E 60.1 mg/ kg , 用其叶加工饮品具有保健作用。     

农药酶免疫分析技术研究进展

自从酶免疫分析原理提出后，近30年来已获得了巨大的进步，成为农药分析的一个非常重要的方法。本文对农药酶免疫分析技术的原理和测定程序进行了评述．并总结了近年酶免疫分析在农药领域研究中的应用，最后，对农药酶免疫分析技术存在的问题和发展趋势作了讨论。     

除草剂最低致死剂量(MLHD)使用新技术概述

本文论述了荷兰MLHD技术的基本内容、技术原理、应用程序等．并针对荷兰的农业特点、开发背景，对该技术在荷兰与中国的应用前景及可行性等进行了比较分析．作者认为合理地利用该技术将有利于我国农业的可持续发展。     

Gly-Gly肽和Gly-L-Leu肽在蛋鸡肠道内水解的研究

采用蛋鸡离体外翻肠段培养法,将小肠分为十二指肠、空肠前段、中段、后段和回肠五个部位肠段,洗净外翻。2种二肽培养液(Gly-Gly肽和Gly-L-Leu肽溶液)作为两组对照培养液,每种二肽培养液中添加肽酶抑制剂(Bestatin和Amastatin),作为试验培养液,39.5℃培养25min,每5min取样一次,测定培养液中的二肽含量。结果表明,培养5min后,含Gly-Gly肽的对照和试验培养液中均未能检测到完整Gly-Gly肽。而含Gly-L-Leu肽的对照培养液Gly-L-Leu肽的含量降低到16.75％,试验培养液则下降到43.40％。而试验培养液中Gly-L-Leu肽的含量10min后无显著降低(P>0.05)。各培养时段试验培养液Gly-L-Leu含量均显著高于对照培养液(P<0.05)。由此认为,离体肠囊在培养过程中能够迅速释放肠肽酶及一些生物活性物质,快速水解2种二肽。肽酶抑制剂(Bestatin和Amastatin)能抑制Gly-L-Leu的水解,但不能抑制Gly-Gly的水解。     

Molecular epidemiology of two fowl cholera outbreaks on a free-range chicken layer farm.

Two outbreaks of fowl cholera on a multiage free-range egg farm were investigated. The outbreaks occurred in 1994 and 2002. A total of 22 strains of Pasteurella multocida were available for study, 11 from the 1994 outbreak and 11 from the 2002 outbreak. Lesions typical of acute fowl cholera were seen in the 1994 outbreak, whereas both acute and chronic fowl cholera occurred in the 2002 outbreak. The isolates were examined in an extended phenotypic typing methodology, by a P. multocida-specific polymerase chain reaction (PCR), by the Heddleston somatic serotyping scheme, and by restriction endonuclease analysis (REA) typing using the enzyme HpaII. All 22 strains had the same phenotypic properties, all were confirmed as P. multocida by PCR, all were Heddleston serovar 4, and all had the same REA pattern. The results indicate that these 2 outbreaks were caused by the same clone of P. multocida--despite the 8-year time period between the outbreaks.     

利用血液蛋白及酶多态性分析技术鉴定山羊亲缘关系的研究

选择血红蛋白(Hb)、运铁蛋白(Tf)、亮氨酸胺肽酶(LAP)、前白蛋白3(Pa3)、淀粉酶(Amy)对可能为同卵双生波尔山羊的亲缘关系鉴定。结果发现，除淀粉酶(Amy)和亮氨酸胺肽酶(Lap)外，其余位点均有多态性。由蛋白位点的基因型判定羔1、羔2基因型完全一致，是供体后代的概率为75G，受体后代的概率为22．8％，从而确认羔1、羔2的双亲为供体公羊和供体母羊。     

肉仔鸡低血糖-尖峰死亡综合征的流行病学分析和病原初探

自2003年6月份以来，在我国北方肉鸡饲养基地普遍流行了一种主要侵害肉仔鸡的疾病，低血糖-尖峰死亡综合征(HSMS)。HSMS发病日龄集中于10～18日龄．临床表现为突然出现的高死亡率，病鸡头部震颤、运动失调、昏迷、失明、死亡。先后对黑龙江、吉林、辽宁、内蒙古、天津、河北、山东等省进行调查．发现HSMS在这几个省的很多肉鸡饲养区广泛存在。对发生该病的259个肉鸡饲养户的调查结果显示．该病与祖代种鸡没有关系．病原可能来自受污染的父母代种鸡场。平均发病率为17．9％。发病鸡群血糖浓度极显著的下降。从2个发病鸡群的病鸡肠道内容物中观察到病毒颗粒．病毒呈多形性．有囊膜，直径约80-100nm，表面有棒状纤突，长约10-20nm．与冠状病毒类似。     

抗鸡传染性腺胃炎酶标抗体的制备和应用

在前期从患病鸡腺胃内分离到呼肠孤病毒的基础上，以该病毒为免疫原对兔进行免疫制备高免血清，分离纯化IgG，进行辣根过氧化物酶（HRP）标记，并用ELISA双抗体夹心法对山东省青岛、枣庄、泰安等地区采集的传染性腺胃炎的腺胃样品进行检测，结果表明制备的抗鸡传染性腺胃炎呼肠孤病毒的酶标抗体检测传染性腺胃炎特异性强、灵敏度高、较简便。     

Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild‐to‐moderate clinical mastitis in dairy cows with longer lasting udder diseases

A nonblinded, positively controlled, noninferiority trial was conducted to evaluate the efficacy of an alternative, nonantibiotic therapy with Masti Veyxym^® to reduce ineffective antibiotic usage in the treatment of nonsevere clinical mastitis (CM) in cows with longer lasting udder diseases. The solely intramammary treatment with Masti Veyxym^® (three applications, 12 hr apart) and the combined treatment with Masti Veyxym^® and antibiotics as usual on the farm according to label of the respective product were compared with the reference treatment of solely antibiotic therapy. The matched field study was conducted on eight free‐stall dairy farms located in Eastern Germany. Cases of mild‐to‐moderate CM in cows with longer lasting high somatic cell counts in preceding dairy herd improvement test days and with previous CM cases in current lactation were randomly allocated to one of the three treatment groups. A foremilk sample of the affected quarter was taken before treatment and again approximately 14 days and 21 days after the end of therapy for cyto‐bacteriological examination. Primary outcomes were clinical cure (CC) and no CM recurrence within 60 days after the end of treatment (no R60). Bacteriological cure (BC) and quarter somatic cell count (QSCC) cure were chosen as secondary outcomes although low probabilities of BC and QSCC cure for selected cows were expected. The study resulted in the following findings: the pathogens mostly cultured from pretreatment samples were Streptococcus uberis, followed by Staphylococcus aureus and coagulase‐negative staphylococci. There were no significant differences between the two test treatments in comparison with the reference treatment regarding all outcome variables. The sole therapy with Masti Veyxym^® resulted in a numerically lower likelihood of BC without significant differences to the reference treatment. The combined therapy group showed a numerically higher nonrecurrence rate than the two other treatment groups and noninferiority compared to the reference treatment was proven. Having regard to the selection criteria of cows in this study, the findings indicated that sole treatment with Masti Veyxym^® in nonsevere CM cases may constitute an alternative therapy to reduce antibiotics. However, noninferiority evaluations were mostly inconclusive. Further investigations with a larger sample size are required to confirm the results and to make a clear statement on noninferiority.